Dr Sullivan is the Managing Director of Lindville Bio, an ATMP consultancy service specializing in the scalable manufacture of Pluripotent Stem Cells (PSC/iPSC) and therapeutic development therefrom. With more than 20 years experience in the ATMP space, Stephen focuses on the development and translation of pluripotent and induced-pluripotent stem cell therapeutics to the clinic.